Neurotechnology Trends, and the Neurosoftware Market

by

The Neu­rotech­nol­o­gy Indus­try Orga­ni­za­tion (NIO) just announced the top ten emerg­ing areas of neu­ro­science that will “impact the future of treat­ments for brain and ner­vous sys­tem”: Top 10 Neu­ro­science Trends in 2007.

It pro­vides superb food for thought. And some of them will sound famil­iar to read­ers of this blog:

* 6. Nor­mal brain aging gets more atten­tion: More research and devel­op­ment is being focused on think­ing impair­ments that only par­tial­ly lim­it inde­pen­dence and qual­i­ty of life for senior cit­i­zens, adults and school aged chil­dren. Neu­rosoft­ware will pen­e­trate nurs­ing homes and schools, as brain fit­ness soft­ware becomes new first-line treat­ment strategy.
* 8. Pre­ven­tion evi­dence grows: You are what you eat; smok­ing is as bad as we thought; and new stud­ies reveal the effects of envi­ron­men­tal sub­stances on Alzheimer’s dis­ease, Parkin­son’s dis­ease and others.
* 9. Emo­tion­al dis­or­ders research advances:  New research con­tin­ues to link neu­ro­ge­n­e­sis to treat­ment of depres­sion.  A bet­ter under­stand­ing of PTSD should lead to new treat­ment regimes.

Want to read prob­a­bly the best overview of the neurosoftware/ brain fit­ness soft­ware mar­ket? Check this arti­cle, fresh from the oven: Thank Boomers for Buff­ing Up Brain Mar­ket.

To clar­i­fy the num­bers men­tioned: we project $225m in the US alone (grow­ing from $70m in 2003), bro­ken-down as fol­lows: $80m for the Con­sumer seg­ment, $60m in K12 Edu­ca­tion, $50m in Clin­i­cal appli­ca­tions, and $35m in the Cor­po­rate seg­ment. The Con­sumer seg­ment, with a healthy aging val­ue propo­si­tion, is the most recent one but the most rapid­ly growing.